Lupus
Does Lack of Pain Mean Lack of Complications for Patients With Lupus?
Published data indicate that for patients who have lupus, monitoring for kidney disease—even in the absence ...
AUGUST 2, 2024
FDA Approves Saphnelo, First New Treatment for Lupus in 10 Years
This marks the first regulatory approval for a type I interferon receptor antagonist, which plays a central role in ...
AUGUST 4, 2021
FDA Approves Lupkynis for Lupus Nephritis
Lupus nephritis is one of the most serious and common complications of systemic lupus erythematosus.
FEBRUARY 3, 2021
FDA Grants New Indication for Benlysta to Lupus Nephritis
The FDA granted a new indication for IV and subcutaneous Benlysta to treat adults with active lupus nephritis, who ...
DECEMBER 18, 2020
Drug Shows Promise in Reversing Kidney Damage Caused by Lupus
T cells implicated in lupus express a factor called hypoxia-inducible factor-1, which is regulated by oxygen levels ...
MAY 22, 2020
Hydroxychloroquine for RA and Lupus Poses Vision Risk
Guidelines to minimize vision loss from hydroxychloroquine are not being fully heeded.
MARCH 11, 2016
